CPAP治疗对老年中度阻塞性睡眠呼吸暂停的作用:多中心随机对照试验
该开放标签多中心随机对照试验纳入145例≥70岁中度OSA患者,随机分为CPAP组(n=73)和无CPAP组(n=72),治疗3个月。结果显示CPAP组ESS评分改善更显著(校正差值2.6分,95%CI 3.6-1.6),部分睡眠相关症状和QSQ维度也有改善,但神经认知测试和血压无显著变化。
要点
- CPAP可显著改善老年中度OSA患者的日间嗜睡(ESS评分改善2.6分)。
- CPAP对部分睡眠相关症状和生活质量维度有改善作用。
- CPAP对神经认知功能、焦虑抑郁和血压水平未见明显效果。
核心结论
- CPAP治疗可显著改善老年中度OSA患者的日间嗜睡、部分睡眠相关症状及生活质量维度。
研究设计与样本
- 开放标签、随机、多中心临床试验,纳入145例≥70岁中度OSA患者(AHI 15-29.9次/小时),随机分为CPAP组(n=73)和无CPAP组(n=72),治疗3个月,按意向性分析。
主要发现
- CPAP组ESS评分改善更显著,校正差值2.6分(95%CI 3.6-1.6),效应量1。
- CPAP组在QSQ问卷的夜间症状维度(-0.7分,95%CI -0.3至-1.0,p<0.0001)和情绪维度(-0.4分,95%CI -0.1至-0.7,p=0.023)有改善。
- CPAP对神经认知测试(包括焦虑和抑郁)及血压水平无显著影响。
- CPAP效果与ESS评分改善及生活质量维度改善呈正相关。
临床怎么用
- 对于老年中度OSA患者,CPAP可考虑用于改善日间嗜睡和部分睡眠相关生活质量。
- 不应期望CPAP在短期内改善神经认知功能或血压。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The efficacy of continuous positive airway pressure (CPAP) treatment in elderly patients with nonsevere obstructive sleep apnoea (OSA) is controversial. The objective of this study was to assess the effect of CPAP treatment in elderly patients with moderate OSA in terms of clinical, quality-of-life and neurocognitive measures.This was an open-label, randomised, multicentre clinical trial in 145 elderly patients (≥70 years old) with confirmed moderate OSA (apnoea-hypopnoea index 15-29.9 events·h-1) randomised to receive CPAP (n=73) or no CPAP (n=72) for 3 months. The primary end-point was the Epworth Sleepiness Scale (ESS) score, and the secondary end-points included quality of life (Quebec Sleep Questionnaire (QSQ) domain scores), sleep-related symptoms, presence of anxiety/depression, office-based blood pressure measurements and some neurocognitive tests. The analysis was performed according to the intention-to-treat principle.Mean±sd age was 74.9±4.6 years. The CPAP group achieved a greater improvement in the ESS score (adjusted difference of 2.6 (95% CI 3.6-1.6) points; effect size 1) in some sleep-related symptoms and in some dimensions of the QSQ questionnaire (nocturnal symptoms: -0.7 (95% CI -0.3--1.0) points; p<0.0001 and emotions: -0.4 (95% CI -0.1--0.7) points; p=0.023). However, CPAP did not demonstrate any effect on either neurocognitive tests (including anxiety and depression) or blood pressure levels. There was a positive correlation between the effect of CPAP and the improvement in ESS scores and quality of life domains.CPAP treatment resulted in a significant improvement in diurnal hypersomnia and some sleep-related symptoms and quality of life domains in elderly patients with moderate OSA.
引用
- Ponce S, Pastor E, Orosa B, et al. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J. 2019. PMID: 31164429. doi:10.1183/13993003.00518-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。